Invest-NL, an Amsterdam-based national financing and development body, has injected €7.5M into Forbion BioEconomy Fund I, a new investment strategy by the life sciences venture capital firm, Forbion. This move aligns with Invest-NL’s focus on backing innovative solutions that cater to sustainability within key sectors such as Food, Agriculture, Materials, and Environment Technologies. Forbion has been at the forefront of identifying and nurturing companies that have validated their products, emphasizing a commitment to sustainable advancements.
In earlier coverage, the Forbion BioEconomy Fund I was noted for its strategic focus on fostering biotech innovations aimed at sustainable development. The fund’s objective aligns with the growing demand for investment in biotechnology, a sector where additional expertise and capital are crucial. The ongoing investment in this field underscores a sustained interest and need for growth in life sciences ventures, aimed at addressing contemporary environmental challenges.
How does Forbion support biotech growth?
Forbion aids biotech companies during their expansion phases across the Netherlands and Europe. With a history of raising significant capital, including €2B for Forbion Growth Opportunities III and Forbion Ventures VII, Forbion’s assets under management have reached €5B. This robust backing ensures that the companies within their portfolio receive not only financial support but also strategic guidance for sustainable growth.
What is Invest International’s role?
Invest International, based in The Hague, adds another €10M to the Forbion BioEconomy Fund, further demonstrating their commitment to impact investing. This institution provides financial support to Dutch enterprises and partner governments globally, highlighting its strategic role in nurturing the biotech sector. Their investments, such as a €10M senior loan to Organic Development Finance, emphasize their focus on helping SMEs in emerging markets.
Forbion, headquartered in Naarden, Netherlands, is recognized globally for investing in biotech innovations across (bio-) pharmaceutical development stages, managing approximately €5B. The venture capital firm prioritizes investments that contribute positively to both human health and environmental sustainability while also meeting financial objectives. The firm invests in cutting-edge products like alternative proteins and biobased materials, reinforcing its commitment to sustainable biotech advancements.
Forbion’s investment strategy reflects a balanced approach of environmental concern and economic gain. With substantial capital raised, Forbion is well-positioned to support companies that are at the forefront of sustainable biotechnology solutions. Their focus on companies with proven products ensures a lower risk while pursuing high-impact innovations.
The significance of the Forbion BioEconomy Fund I lies in its targeted investment approach within a heavily specialized sector. By concentrating on established companies with demonstrable products, Forbion mitigates investment risks while pushing forward its sustainability agenda. The addition of Invest-NL and Invest International as partners further strengthens the fund’s capacity to drive change.
